To all members of the Faculty of Medicine, including all learners:

McGill University is closely monitoring the COVID-19 situation as it continues to rapidly evolve. When providing the community with advice, the University is following the guidelines of Quebec and Canada’s Public Health authorities. As members of the Faculty and health care system, we must exercise extra vigilance to contain the spread of the virus.

Faculty-hosted Conferences and Other Events

Congratulations to the Sharif Lab for the recent publication of their paper, TACAN Is an Ion Channel Involved in Sensing Mechanical Pain, in the prestigious journal Cell. Their identification of a mechanical pain sensor lays the groundwork for designing new drugs to treat pain. Great job! 

Photo (left to right): Marine Christin, co-first author and Reza Sharif-Naeini, senior author.

By Gillian Woodford

A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a McGill-led study has found.

Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer.

McGill researchers identify new markers for early detection of cervical cancer

By Ashley Rabinovitch

By Monica Slanik, School of Physical and Occupational Therapy

Daniel Almeida, a PhD student under the supervision of Dr. Gustavo Turecki in McGill University’s Integrated Program in Neuroscience and at the Douglas Research Centre, was included in Forbes Magazine’s Top 30 under 30 list, unveiled December 3. Overall, the ninth annual list includes 600 young entrepreneurs, risk-takers and game changers who are redefining what it means to innovate and lead by example.

New guideline from the Canadian Task Force on Preventive Health Care

A new guideline from the Canadian Task Force on Preventive Health Care found no benefit of routine screening for thyroid dysfunction in adults without symptoms or risk factors. Based on the latest evidence, the Task Force guideline recommends against routine screening for thyroid dysfunction in non-pregnant adults and is published in CMAJ (Canadian Medical Association Journal).